Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NPC”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06787456
What this trial is testing

"Xijiang Project" Screening Cohort for NPC

Who this might be right for
Nasopharyngeal Carcinoma (NPC)Screening
Ming-Yuan Chen 1,000,000
Not applicableWithdrawnNCT02289807
What this trial is testing

Concurrent Chemotherapy in Intermediate Risk Patients Treated With Intensity-modulated Radiotherapy

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07555860
What this trial is testing

Becotatug Vedotin Plus PD-1 Monoclonal Antibody and Radiotherapy for Unresectable Locally Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 28
Not applicableLooking for participantsNCT06688760
What this trial is testing

Surgery Alone Verus Sugery Combined with Dose-reduced Radiotherapy for Newly Diagnosed Stage I Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaSurgeryRadiotherapy
Ming-Yuan Chen 86
Early research (Phase 1)Ended earlyNCT00023790
What this trial is testing

Photodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the Skin

Who this might be right for
Breast CancerHead and Neck CancerLymphoma+3 more
Case Comprehensive Cancer Center 3
Not applicableStudy completedNCT00341146
What this trial is testing

Molecular Genetics Study of Nasopharyngeal Carcinoma: Characterization of NCP Susceptibility Gene(s)

Who this might be right for
Nasopharyngeal Carcinoma
National Cancer Institute (NCI) 6,490
Not applicableStudy completedNCT00896896
What this trial is testing

Immunoreactivity to Cetuximab in Cancer Patients

Who this might be right for
Colorectal CancerHead and Neck Cancer
Vanderbilt-Ingram Cancer Center 538
Large-scale testing (Phase 3)UnknownNCT00677118
What this trial is testing

Adjuvant Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 506
Not applicableLooking for participantsNCT03353467
What this trial is testing

Endoscopic Nasopharyngectomy for Newly Diagnosed Stage I Nasopharyngeal Carcinoma Patients

Who this might be right for
Nasopharyngeal CarcinomaEndoscopic SurgeryPrimary Napharyngeal Carcinama+1 more
Sun Yat-sen University 228
Not applicableActive Not RecruitingNCT05531916
What this trial is testing

Compression Therapy as a Prophylactic Method Against CIPN: a Prospective Self-controlled Trial

Who this might be right for
Nasopharyngeal CarcinomaCIPN - Chemotherapy-Induced Peripheral Neuropathy
Sun Yat-sen University 182
Testing effectiveness (Phase 2)Study completedNCT01712919
What this trial is testing

Chemoradiation Plus Weekly c225 Against Locoregionally Advanced Nasopharyngeal Carcinoma (NPC)

Who this might be right for
Nasopharyngeal Carcinoma
Jiangsu Cancer Institute & Hospital 61
Not applicableStudy completedNCT00828516
What this trial is testing

Using Traditional Acupuncture in the Management of Cancer Treatment Related Lymphoedema

Who this might be right for
Breast CancerHead and Neck CancerLymphedema
East and North Hertfordshire NHS Trust 56
Not applicableUnknownNCT01237704
What this trial is testing

Dysphagia Rehabilitation for Nasopharyngeal Carcinoma Patients Post Radiotherapy

Who this might be right for
Nasopharyngeal CarcinomaRadiotherapy
Chinese University of Hong Kong 160
Testing effectiveness (Phase 2)Study completedNCT03674567
What this trial is testing

Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination With Pembrolizumab

Who this might be right for
Advanced Cancer
RAPT Therapeutics, Inc., a member of the GSK plc group of companies 323
Not applicableLooking for participantsNCT04085900
What this trial is testing

Screening Nasopharyngeal Carcinoma With EBV Associated Biomarkers in Zhongshan City

Who this might be right for
Nasopharyngeal Carcinoma
Zhongshan People's Hospital, Guangdong, China 40,000
Testing effectiveness (Phase 2)Looking for participantsNCT05290194
What this trial is testing

Radiotherapy Combined With PD-1 Monoclonal Antibody and Capecitabine in the Treatment of Nasopharyngeal Carcinoma

Who this might be right for
RadiotherapyPD-1 InhibitorCapecitabine+1 more
Fifth Affiliated Hospital, Sun Yat-Sen University 28
Large-scale testing (Phase 3)Active Not RecruitingNCT05294172
What this trial is testing

KL-A167 Injection Combined With Cisplatin and Gemcitabine vs Placebo Combined With Cisplatin and Gemcitabine in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaRecurrent or Metastatic
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 295
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07824856
What this trial is testing

Local Ablation Plus Systemic Therapy for Metachronous Liver and/or Lung Oligometastases From Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaNeoplasm MetastasisLung Metastases+3 more
Sun Yat-sen University 138
Large-scale testing (Phase 3)Looking for participantsNCT04448522
What this trial is testing

Reduced vs Conventional Dosage Intensity-modulated Radiotherapy for Chemotherapy-sensitive Stage II-III Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaRadiotherapyChemotherapy
Sun Yat-sen University 508
Testing effectiveness (Phase 2)UnknownNCT04405622
What this trial is testing

Toripalimab and Gemcitabine in Recurrent or Metastatic Nasopharyngeal Carcinoma.

Who this might be right for
Nasopharyngeal CarcinomaRecurrent Nasopharyngeal CarcinomaMetastatic Nasopharyngeal Carcinoma+2 more
Sun Yat-sen University 21
Next Page